UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000042837
Receipt number R000048905
Scientific Title The safety of ureteroscopic lithotripsy for the elderly patients
Date of disclosure of the study information 2021/04/01
Last modified on 2022/12/28 19:50:32

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

The safety of ureteroscopic lithotripsy for the elderly patients

Acronym

The safety of ureteroscopic lithotripsy for the elderly patients

Scientific Title

The safety of ureteroscopic lithotripsy for the elderly patients

Scientific Title:Acronym

The safety of ureteroscopic lithotripsy for the elderly patients

Region

Japan


Condition

Condition

upper urinary tract stone

Classification by specialty

Urology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To evaluate the safety of ureteroscopic lithotripsy for the elderly patients

Basic objectives2

Safety

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

The incidence of postoperative complications and their types

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

15 years-old <=

Age-upper limit

105 years-old >

Gender

Male and Female

Key inclusion criteria

Patients who underwent ureteroscopic lithotripsy for the first time in our institution from April 2016 to March 2020 are included.

Key exclusion criteria

Patients who underwent repeated ureteroscopic lithotripsy within 2 months, PNL or only ureteral stent placement.

Target sample size

500


Research contact person

Name of lead principal investigator

1st name Ryoji
Middle name
Last name Takazawa

Organization

Tokyo Metropolitan Ohtsuka Hospital

Division name

Urology

Zip code

170-8476

Address

2-8-1 Minami-Ohtsuka, Toshima-ku, Tokyo, Japan

TEL

0339413211

Email

angel_sapporo_0329@yahoo.co.jp


Public contact

Name of contact person

1st name Ryoji
Middle name
Last name Takazawa

Organization

Tokyo Metropolitan Ohtsuka Hospital

Division name

Urology

Zip code

170-8476

Address

2-8-1 Minami-Ohtsuka, Toshima-ku, Tokyo, Japan

TEL

0339413211

Homepage URL


Email

angel_sapporo_0329@yahoo.co.jp


Sponsor or person

Institute

Tokyo Metropolitan Ohtsuka Hospital

Institute

Department

Personal name



Funding Source

Organization

Tokyo Metropolitan Ohtsuka Hospital

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Tokyo Metropolitan Ohtsuka Hospital

Address

2-8-1 Minami-Ohtsuka, Toshima-ku, Tokyo, Japan

Tel

0339413211

Email

angel_sapporo_0329@yahoo.co.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2021 Year 04 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2021 Year 04 Month 01 Day

Date of IRB

2021 Year 03 Month 17 Day

Anticipated trial start date

2021 Year 04 Month 01 Day

Last follow-up date

2022 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

Nothing


Management information

Registered date

2020 Year 12 Month 24 Day

Last modified on

2022 Year 12 Month 28 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000048905


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name